InnoCare Pharma Limited (9969.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for InnoCare Pharma Limited, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 30.69x |
| P/B Ratio | 2.52x |
| P/S Ratio | 8.47x |
| Profitability | |
| Gross Margin | 87.6% |
| Operating Margin | 19.2% |
| Net Margin | 27.2% |
| EBITDA Margin | 24.2% |
| Liquidity | |
| Current Ratio | 5.83x |
| Quick Ratio | 5.71x |
| Leverage | |
| Debt/Equity | 0.21x |
YoY = year-over-year change. Source: FMP..